August 16, 2018 The current issue of The Lancet, one of the oldest and most prestigious medical journals, features a new study from the Population Health Research Institute (PHRI) of McMaster University and Hamilton Health Sciences. The study shows that for the vast majority of people there is no health benefit from a low salt […]Continue Reading ...
August 14, 2018 Digital pharmacy to transform lives of chronic care patients across Merseyside Thirty jobs are to be created through a new £1.5m ‘Tele-Pharmacy’opening in Liverpool, aimed at helping people living with chronic care conditions to manage their medicinal needs through the UK’s only artificial intelligent mobile app ‘Now Patient’. Liverpool has been highlighted […]Continue Reading ...
August 14, 2018 New technology developed by a team of McGill University scientists shows potential to streamline the analysis of proteins, offering a quick, high volume and cost-effective tool to hospitals and research labs alike. Proteins found in blood provide scientists and clinicians with key information on our health. These biological markers can determine if […]Continue Reading ...
August 10, 2018 HRL Laboratories, LLC, in collaboration with University of New Mexico (UNM), have published the first study showing that transcranial alternating current stimulation (tACS) of the brain during sleep increases human subjects’ ability to accurately assess hidden targets in novel visual scenes. The new “closed-loop” method effectively reduces the typical overnight drop in […]Continue Reading ...
August 10, 2018 A new area in depression research suggests dysfunction in mitochondria — the main source of energy for cells — could lead to major depression. Published in Frontiers in Neuroscience, this new insight to long-held theories on the causes of depression could lead to the development of novel and more effective antidepressant drugs. […]Continue Reading ...
August 10, 2018 A new type of bed net could prevent millions of cases of malaria, according to new research published in The Lancet today (10 August). The two-year clinical trial in Burkina Faso, West Africa involving 2,000 children showed that the number of cases of clinical malaria was reduced by 12 per cent with […]Continue Reading ...
3D Printing Technology and Personalized Medicine Professor Abu Serajuddin At St. John’s, we are building an innovation center in pharmaceutical technology. We are involved with double upping new drug delivery systems, as well as a new processing agreement. In addition, we are focussing on personalized medications.Continue Reading ...
Any thought you’ve ever had, any motion you’ve ever made, any twinge of pain you’ve ever felt is the result, in part, of neurons in the brain and throughout your body sending chemical signals from one to the next. Now, Stanford scientists are a step closer to actually watching those signals as they take shape […]Continue Reading ...
PET scan of a human brain with Alzheimer’s disease. Credit: public domain The decadeslong search for effective ways to treat or prevent Alzheimer’s disease is littered with failures, leaving 5.7 million Americans already stricken with this form of dementia without a lifeline. The rest of us are left to hope we won’t be among the […]Continue Reading ...
Researchers at Cleveland Clinic in the United States have designed a potential new class of drugs that may reduce cardiovascular risk by targeting a specific microbial pathway in the gut. Unlike antibiotics, which non-specifically kill gut bacteria and can lead to adverse side effects and resistance, the new class of compounds prevents microbes from making […]Continue Reading ...
August 9, 2018 Since the development of insulin to manage diabetes, pharmacists have longed to create an insulin pill. Past attempts have failed because insulin does not survive the harsh conditions of the gastro-intestinal (GI) systemand cannot easily cross the GI wall. Researchers at University of Utah Health developed a proof-of-concept technology using nanoparticles that […]Continue Reading ...
August 9, 2018 Researchers at Columbia University Irving Medical Center (CUIMC) have found new evidence of how certain transport proteins are working at the molecular level, paving the way for new, improved drugs to treat psychiatric disorders. The study’s findings have been published in the prestigious Proceedings of the National Academy of Sciences of the […]Continue Reading ...
August 9, 2018 Researchers from ITMO University developed and tested an MRI coil providing high-resolution imaging of the whole body of a mouse. Such coils are used in preclinical testing, as well as in imaging of various body systems. The new coil produces images with three times higher resolution than standard commercial volume MRI coils. […]Continue Reading ...
Treatment for Pain Nektar Therapeutics Announces New Drug Application for NKTR-181 Accepted for Review by FDA SAN FRANCISCO, July 30, 2018 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today announced that the U.S. Food and Drug Administration (FDA) has filed and accepted for review the company’s New Drug Application (NDA) for NKTR-181 for the treatment of […]Continue Reading ...
August 7, 2018 Depression is one of the most common diseases that affects at least 4.4% of the world population since 2015. Current antidepressants are limited by their undesirable side effects and slow onset. The development of drugs for depression is particularly challenging due to the complexity of the symptoms, heterogeneity and comorbid diagnosis. Indeed, […]Continue Reading ...
- Study shows DNA methylation related to liver disease among obese patients
- Life on the border: Back at Stanford, ready to pitch in
- New device for accurately placing hemodialysis catheters on kidney patients
- New strategy accelerates, automates process of prototype molecule optimization
- Study finds role of autoimmunity in development of COPD
- Researchers transform research tool to study neuronal function
- Cognitive impairment does not equate to unhappiness in older adults
- Peer Comparisons Can Decrease Risky Prescribing Patterns
- Susceptible genes identified for childhood chronic kidney disease
- Research uncovers miscarriage cause, identifies potential targets for treatment
- Bacterial armor could be new target for antibiotics | News Center
- FDA expands approval of Vertex’ cystic fibrosis medicine to treat children aged 12 to
- Give Your Child a Head Start With Math
- Ground-breaking study tests whether rejected livers can be made viable for transplantation
- New algorithm could improve diagnosis of rare diseases | News Center
- SCHILLER introduces latest generation of ECG device, CARDIOVIT AT-102 G2
- Proper treatment, refraining from smoking can reduce heart disease risk from type 2 diabetes
- Mount Sinai study could transform treatment for patients with retinal degenerative diseases
- Penn researchers develop first mouse model of idiopathic pulmonary fibrosis
- Four tips to help prevent fall allergy symptoms